Syndax Pharmaceuticals Inc ($SNDX)
Filing Information
| Accession Number | 0001193125-26-299803 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 9, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
97,125
Total Value
$991,328.98
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jul 8, 2026 | Exercise/Conversion | 32,375 | $6.38 | $206,552.50 | 517,218 | Direct | โ | View Details | |
Director | Common Stock | โ | Jul 8, 2026 | Sale | 32,375 | $24.24 | $784,776.48 | 484,843 | Direct | โ | View Details | |
Director | Stock Option (Right to buy) | Derivative | Jul 8, 2026 | Exercise/Conversion | 32,375 | $0.00 | $0.00 | 0 | Direct | โ | View Details |